TimeStamp

Company Overview

Snapshot

Founded in April 2017 by Amir Elhasid and Ian Solomon, TimeStamp operates with 1–10 employees. The company has completed one funding round. TimeStamp ceased operations in July 2025.

Business overview

TimeStamp develops smart sticker technology designed to bring real-world medication adherence data into healthcare systems without requiring direct patient engagement. Its proprietary Smart Stickers attach to common drugs and utilize AI-powered algorithms to detect specific usage events, such as dose loading, orientation, and inhalations for inhalers, or shaking and squeezing for eye-drop bottles. This data is uploaded to the TimeStamp cloud via a transparent background process, enabling more personalized patient care for healthcare systems. The company's technology serves the Health Tech & Life Sciences sector, focusing on digital healthcare, patient remote monitoring, and pharmaceuticals, with a B2B business model.

Company Intelligence Q&A

What is TimeStamp's primary focus?

TimeStamp focuses on developing smart sticker technology to track medication adherence in real-time, providing data to healthcare systems without requiring active patient input.

When was TimeStamp founded?

TimeStamp was founded in April 2017.

Who are the co-founders of TimeStamp?

TimeStamp was co-founded by Amir Elhasid and Ian Solomon.

What is the current operational status of TimeStamp?

TimeStamp ceased to operate in July 2025.

What technology does TimeStamp utilize?

TimeStamp utilizes proprietary Smart Stickers with AI-powered algorithms and cloud-based data processing to detect and transmit medication usage events.